RETRACTED: MiR-370-5p inhibits the progression of breast cancer via targeting LUC7L3 (Retracted Article)

被引:10
|
作者
Sang, Kai [1 ]
Yi, Tongbo [1 ]
Huang, Xinxin [2 ]
Pan, Chi [1 ]
Zhou, Jian [1 ]
Yu, Lei [3 ]
机构
[1] Jiangsu Taizhou Peoples Hosp, Dept Breast Surg, Taizhou, Peoples R China
[2] Taizhou Fourth Peoples Hosp, Dept Pediat, Taizhou, Peoples R China
[3] Jiangsu Taizhou Peoples Hosp, Dept Oncol, 399 Hailing Rd, Taizhou 225300, Peoples R China
关键词
MiR-370-5p; breast cancer; proliferation; invasion; MICRORNAS;
D O I
10.1080/10799893.2020.1819319
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer is one of the most common malignancies and one of the leading causes of cancer-induced mortality among women. Over the past decades, the occurrence of breast cancer has been a significant increase. As documented in numerous researches, microRNAs (miRNAs) play vital roles in a wide range of biological processes associated with the occurrence and development of breast cancer. Nevertheless, the role of miR-370-5p in breast cancer remains obscure, and the possible molecular regulatory mechanism needs to be further explored. In this study, our results delineated that miR-370-5p was downregulated in breast cancer tissues and cell lines. Besides, miR-370-5p overexpression suppressed cell proliferation and invasion in breast cancer. MiR-370-5p downregulation exerted an opposite result. In addition, LUC7L3 was identified as a target gene for miR-370-5p. Similar with the results induced by miR-370-5p overexpression, LUC7L3 knockdown attenuated the proliferation and invasion ability of breast cancer cells. Moreover, the alternation of LUC7L3 expression reversed the regulatory effects of miR-370-5p on cell phenotypes in breast cancer. Overall, miR-370-5p may exert antitumor effect on breast cancer. Hence, miR-370-5p may serve as a novel therapeutic marker for the treatment of patients with breast cancer.
引用
收藏
页码:442 / 450
页数:9
相关论文
共 50 条
  • [1] RETRACTION: MiR-370-5p inhibits the progression of breast cancer via targeting LUC7L3 (Retraction of Vol 41, Pg 442, 2021)
    Sang, Kai
    Yi, Tongbo
    Huang, Xinxin
    Pan, Chi
    Zhou, Jian
    Yu, Lei
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (02) : 214 - 214
  • [2] RETRACTED: Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p (Retracted Article)
    Zhang, Li
    Ding, Fengping
    ONCOTARGETS AND THERAPY, 2019, 12 : 6577 - 6589
  • [3] RETRACTED: miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1 (Retracted Article)
    Zhao, Wei
    Zhao, Yingyan
    Chen, Ling
    Sun, Yan
    Fan, Sumei
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [4] RETRACTED: MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2 (Retracted Article)
    Hu, Shaojun
    Song, Yang
    Zhou, Yu
    Jiao, Yu
    Wang, Song
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [5] RETRACTED: miR-539 inhibits human colorectal cancer progression by targeting RUNX2 (Retracted Article)
    Wen, Dacheng
    Li, Songhe
    Jiang, Weidong
    Zhu, Jiaming
    Liu, Jingjing
    Zhao, Shutao
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1314 - 1320
  • [6] RETRACTED: Downregulation of miR-487a-3p suppresses the progression of non-small cell lung cancer via targeting Smad7 (Retracted Article)
    Fan, Youqiang
    Hao, Jingduo
    Cen, Xueying
    Song, Kun
    Yang, Chunbo
    Xiao, Shengwen
    Cheng, Siming
    DRUG DEVELOPMENT RESEARCH, 2022, 83 (02) : 564 - 564
  • [7] RETRACTED: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52 (Retracted Article)
    Li, Yuanbo
    Sun, Yan
    Li, Zhenlu
    Li, Shikuan
    Wu, Changliang
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [8] RETRACTED: LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p (Retracted Article)
    Han, Xiancheng
    Liu, Jing
    Liu, Yongguo
    Mou, Linkai
    Li, Chunlong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4393 - 4401
  • [9] RETRACTED: miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer (Retracted Article)
    Lin, Yuanqiang
    Cheng, Kailiang
    Wang, Tongtong
    Xie, Qian
    Chen, Minglong
    Chen, Qianqian
    Wen, Qiang
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1718 - 1724
  • [10] RETRACTED ARTICLE: miR-217-5p Inhibits Invasion and Metastasis of Prostate Cancer by Targeting Clusterin
    Wanli Zhao
    Xiuli Wang
    Yuqing Jiang
    Xiaopeng Jia
    Yuexian Guo
    Mammalian Genome, 2021, 32 : 371 - 380